Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.26% vs 43.47% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 151.13% vs -82.58% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 24.33% vs -45.20% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 5.13% vs 1.74% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Northeast Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -2.26% vs 43.47% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -14.66% vs 3.72% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 151.13% vs -82.58% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -16.99% vs 49.58% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 24.33% vs -45.20% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -10.86% vs 77.94% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 5.13% vs 1.74% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -32.04% vs -12.56% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






